SLC39A4 and pancreatic neoplasm: explained a potential mechanism in their study: SLC39A4 mediates pancreatic cancer cell growth by upregulating the expression of neuropilin‐1 (NRP‐1), vascular endothelial growth factor (VEGF), and matrix metalloproteases (MMPs) in cell lines and xenografts.32